MindWalk Holdings (HYFT) Income towards Parent Company (2020 - 2026)
MindWalk Holdings' (HYFT) quarterly Income towards Parent Company came in at -$2.5 million in Q2 2026, up 81.16% year-over-year from -$1.4 million in Q2 2025, and up 6.19% quarter-over-quarter from -$2.7 million in Q1 2026.
Analysis
MindWalk Holdings (HYFT) Income towards Parent Company (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported Income towards Parent Company for 7 consecutive years, with -$2.5 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Income towards Parent Company rose 81.16% year-over-year to -$2.5 million in Q2 2026; TTM through Apr 2026 was -$6.1 million, a 82.68% increase from a year earlier, with the FY2026 full-year figure at -$1.0 million, up 86.99% from the prior year.
- Income towards Parent Company was -$2.5 million for Q2 2026 at MindWalk Holdings, up from -$2.7 million in the prior quarter.
- Over five years, Income towards Parent Company peaked at $1.0 million in Q3 2025 and troughed at -$3.0 billion in Q3 2023.
- A 5-year average of -$296.7 million and a median of -$3.9 million in 2022 frame the typical range for Income towards Parent Company.
- Across the five-year window, Income towards Parent Company plunged 40254.8% in 2023 and soared 1244.85% in 2025, its largest moves.
- Over 5 years, Income towards Parent Company stood at -$5.5 million in 2022, then tumbled by 39915.91% to -$2.2 billion in 2023, then surged by 99.87% to -$2.8 million in 2024, then grew by 29.21% to -$2.0 million in 2025, then decreased by 27.0% to -$2.5 million in 2026.
- The last three Income towards Parent Company figures came in at -$2.5 million (Q2 2026), -$2.7 million (Q1 2026), and -$2.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -2.50 Mn |
| Jan 31, 2026 | -2.66 Mn |
| Oct 31, 2025 | -1.97 Mn |
| Jul 31, 2025 | 1.01 Mn |
| Apr 30, 2025 | -13.25 Mn |
| Jan 31, 2025 | -19.33 Mn |
| Oct 31, 2024 | -2.78 Mn |
| Jul 31, 2024 | 75,222.13 |
| Apr 30, 2024 | -17.56 Mn |
| Jan 31, 2024 | -3.05 Mn |
| Oct 31, 2023 | -2.21 Bn |
| Jul 31, 2023 | -3.03 Bn |
| Apr 30, 2023 | -5.82 Mn |
| Jan 31, 2023 | -3.32 Mn |
| Oct 31, 2022 | -5.53 Mn |
| Jul 31, 2022 | -7.52 Mn |
| Apr 30, 2022 | -4.19 Mn |
| Jan 31, 2022 | -3.57 Mn |
| Oct 31, 2021 | -3.88 Mn |
| Jul 31, 2021 | -2.97 Mn |